These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 28, 2014 |
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Transition Period from _____ to _____
|
|
Delaware
|
|
57-0426694
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
775 Spartan Blvd, Suite 102, P.O. Box 5627, Spartanburg, South Carolina
|
|
29304
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
(864) 585-3605
|
|
|
(Registrant's telephone number, including area code)
|
||
|
Large accelerated Filer
¨
|
Accelerated filer
x
|
Non-accelerated filer
¨
|
Smaller reporting company
¨
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
|
|
PART I
|
FINANCIAL INFORMATION
|
|
|
|
Item 1
.
|
Financial Statements
|
|
|
|
Condensed consolidated balance sheets - June 28, 2014 and December 28, 2013
|
|
|
|
Condensed consolidated statements of operations - Three and six month periods ended June 28, 2014 and June 29, 2013
|
|
|
|
Condensed consolidated statements of cash flows - Six months ended June 28, 2014 and June 29, 2013
|
|
|
|
Notes to condensed consolidated financial statements
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 4.
|
Controls and Procedures
|
|
|
|
|
|
OTHER INFORMATION
|
||
|
|
Item 1.
|
Legal Proceedings
|
|
|
Item
1A.
|
Risk Factors
|
|
|
Item 6.
|
Exhibits
|
|
|
Signatures and Certifications
|
|
|
|
Jun 28, 2014
|
|
Dec 28, 2013
|
||||
|
|
(Unaudited)
|
|
|
||||
|
Assets
|
|
|
|
||||
|
Current assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
6,088,473
|
|
|
$
|
1,776,763
|
|
|
Accounts receivable, less allowance for doubtful accounts of $1,157,288 and $1,079,288, respectively
|
41,637,616
|
|
|
34,089,364
|
|
||
|
Inventories, net
|
51,985,402
|
|
|
55,856,803
|
|
||
|
Deferred income taxes
|
3,747,854
|
|
|
3,776,647
|
|
||
|
Prepaid expenses and other current assets
|
4,956,953
|
|
|
4,111,775
|
|
||
|
Total current assets
|
108,416,298
|
|
|
99,611,352
|
|
||
|
|
|
|
|
||||
|
Cash value of life insurance
|
2,055,419
|
|
|
2,007,419
|
|
||
|
Property, plant and equipment, net of accumulated
|
|
|
|
||||
|
depreciation of $46,354,461 and $44,229,008, respectively
|
36,570,126
|
|
|
35,883,376
|
|
||
|
Goodwill
|
18,252,678
|
|
|
18,252,678
|
|
||
|
Intangible asset, net
|
6,285,000
|
|
|
6,930,000
|
|
||
|
Deferred charges, net and other non-current assets
|
363,191
|
|
|
575,546
|
|
||
|
Total assets
|
$
|
171,942,712
|
|
|
$
|
163,260,371
|
|
|
|
|
|
|
||||
|
Liabilities and Shareholders' Equity
|
|
|
|
||||
|
Current liabilities
|
|
|
|
||||
|
Accounts payable
|
$
|
18,966,292
|
|
|
$
|
12,430,290
|
|
|
Accrued expenses
|
11,356,202
|
|
|
9,511,528
|
|
||
|
Current portion of long-term debt
|
2,533,908
|
|
|
2,533,908
|
|
||
|
Other current liabilities
|
168,520
|
|
|
147,500
|
|
||
|
Total current liabilities
|
33,024,922
|
|
|
24,623,226
|
|
||
|
|
|
|
|
||||
|
Long-term debt
|
19,637,756
|
|
|
20,904,708
|
|
||
|
Long-term contingent consideration
|
2,445,833
|
|
|
3,362,031
|
|
||
|
Deferred income taxes
|
7,573,999
|
|
|
7,573,999
|
|
||
|
Other long-term liabilities
|
698,594
|
|
|
698,294
|
|
||
|
|
|
|
|
||||
|
Shareholders' equity
|
|
|
|
||||
|
Common stock, par value $1 per share - authorized 12,000,000 shares; issued 10,300,000 shares
|
10,300,000
|
|
|
10,300,000
|
|
||
|
Capital in excess of par value
|
33,822,455
|
|
|
33,657,714
|
|
||
|
Retained earnings
|
78,514,163
|
|
|
76,337,597
|
|
||
|
|
122,636,618
|
|
|
120,295,311
|
|
||
|
Less cost of common stock in treasury: 1,595,847 and 1,612,200 shares, respectively
|
14,075,010
|
|
|
14,197,198
|
|
||
|
Total shareholders' equity
|
108,561,608
|
|
|
106,098,113
|
|
||
|
Commitments and contingencies – See Note 11
|
|
|
|
||||
|
Total liabilities and shareholders' equity
|
$
|
171,942,712
|
|
|
$
|
163,260,371
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
||||||||
|
Net sales
|
$
|
58,796,633
|
|
|
$
|
53,446,594
|
|
|
$
|
111,683,108
|
|
|
$
|
106,931,192
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of sales
|
49,428,433
|
|
|
46,698,407
|
|
|
94,411,906
|
|
|
93,961,022
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Gross profit
|
9,368,200
|
|
|
6,748,187
|
|
|
17,271,202
|
|
|
12,970,170
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Selling, general and administrative expense
|
4,676,177
|
|
|
4,087,392
|
|
|
8,850,338
|
|
|
8,242,406
|
|
||||
|
Acquisition related costs
|
—
|
|
|
13,180
|
|
|
(3,146
|
)
|
|
51,190
|
|
||||
|
Operating income
|
4,692,023
|
|
|
2,647,615
|
|
|
8,424,010
|
|
|
4,676,574
|
|
||||
|
Other (income) and expense
|
|
|
|
|
|
|
|
|
|
||||||
|
Interest expense
|
261,998
|
|
|
372,402
|
|
|
527,686
|
|
|
714,227
|
|
||||
|
Change in fair value of interest rate swap
|
175,695
|
|
|
(495,430
|
)
|
|
294,501
|
|
|
(633,109
|
)
|
||||
|
Palmer earn-out adjustment
|
(3,476,198
|
)
|
|
—
|
|
|
(3,476,198
|
)
|
|
—
|
|
||||
|
Other, net
|
(6,645
|
)
|
|
16,021
|
|
|
(6,645
|
)
|
|
(194
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Income from continuing operations before income taxes
|
7,737,173
|
|
|
2,754,622
|
|
|
11,084,666
|
|
|
4,595,650
|
|
||||
|
Provision for income taxes
|
1,991,000
|
|
|
931,000
|
|
|
3,126,000
|
|
|
1,535,000
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net income from continuing operations
|
5,746,173
|
|
|
1,823,622
|
|
|
7,958,666
|
|
|
3,060,650
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
(Loss) income from discontinued operations, net of tax
|
(5,345,886
|
)
|
|
89,042
|
|
|
(5,782,100
|
)
|
|
317,461
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net income
|
$
|
400,287
|
|
|
$
|
1,912,664
|
|
|
$
|
2,176,566
|
|
|
$
|
3,378,111
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per common share from continuing operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.66
|
|
|
$
|
0.29
|
|
|
$
|
0.92
|
|
|
$
|
0.48
|
|
|
Diluted
|
$
|
0.66
|
|
|
$
|
0.28
|
|
|
$
|
0.91
|
|
|
$
|
0.48
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) income per common share from discontinued operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.61
|
)
|
|
$
|
0.01
|
|
|
$
|
(0.66
|
)
|
|
$
|
0.05
|
|
|
Diluted
|
$
|
(0.61
|
)
|
|
$
|
0.01
|
|
|
$
|
(0.66
|
)
|
|
$
|
0.05
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
8,700,725
|
|
|
6,379,391
|
|
|
8,695,610
|
|
|
6,371,013
|
|
||||
|
Dilutive effect from stock options and grants
|
10,662
|
|
|
58,636
|
|
|
9,353
|
|
|
58,872
|
|
||||
|
Diluted
|
8,711,387
|
|
|
6,438,027
|
|
|
8,704,963
|
|
|
6,429,885
|
|
||||
|
|
Six Months Ended
|
||||||
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
||||
|
Operating activities
|
|
|
|
||||
|
Net income
|
$
|
2,176,566
|
|
|
$
|
3,378,111
|
|
|
Adjustments to reconcile net income to net cash used in operating activities:
|
|
|
|
|
|
||
|
Depreciation expense
|
2,125,451
|
|
|
1,735,226
|
|
||
|
Amortization expense
|
684,701
|
|
|
796,483
|
|
||
|
Deferred income taxes
|
28,793
|
|
|
37,005
|
|
||
|
Palmer earn-out adjustment
|
(3,476,198
|
)
|
|
—
|
|
||
|
Provision for (reduction of) losses on accounts receivable
|
78,000
|
|
|
(35,524
|
)
|
||
|
Provision for losses on inventory
|
2,729,306
|
|
|
739,357
|
|
||
|
Gain on sale of property, plant and equipment
|
—
|
|
|
(3,911
|
)
|
||
|
Cash value of life insurance
|
(48,000
|
)
|
|
(53,999
|
)
|
||
|
Change in fair value of interest rate swap
|
294,501
|
|
|
(633,109
|
)
|
||
|
Environmental reserves
|
21,020
|
|
|
18,823
|
|
||
|
Issuance of treasury stock for director fees
|
110,501
|
|
|
127,989
|
|
||
|
Employee stock option and grant compensation
|
167,381
|
|
|
164,887
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
(7,626,252
|
)
|
|
(5,168,152
|
)
|
||
|
Inventories
|
1,142,095
|
|
|
(7,682,335
|
)
|
||
|
Other assets and liabilities, net
|
257,350
|
|
|
(741,932
|
)
|
||
|
Accounts payable
|
6,536,002
|
|
|
6,946,676
|
|
||
|
Accrued expenses
|
4,262,728
|
|
|
(1,874,048
|
)
|
||
|
Accrued income taxes
|
(1,073,089
|
)
|
|
27,521
|
|
||
|
Net cash provided by (used in) operating activities
|
8,390,856
|
|
|
(2,220,932
|
)
|
||
|
Investing activities
|
|
|
|
|
|
||
|
Purchases of property, plant and equipment
|
(2,812,201
|
)
|
|
(3,062,159
|
)
|
||
|
Proceeds from sale of property, plant and equipment
|
—
|
|
|
103,866
|
|
||
|
Net cash used in investing activities
|
(2,812,201
|
)
|
|
(2,958,293
|
)
|
||
|
Financing activities
|
|
|
|
|
|
||
|
Net borrowings from line of credit
|
—
|
|
|
5,337,965
|
|
||
|
Payments on long-term debt
|
(1,266,952
|
)
|
|
(1,181,469
|
)
|
||
|
Proceeds from exercised stock options
|
7
|
|
|
80,276
|
|
||
|
Net cash (used in) provided by financing activities
|
(1,266,945
|
)
|
|
4,236,772
|
|
||
|
Increase (decrease) in cash and cash equivalents
|
4,311,710
|
|
|
(942,453
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
1,776,763
|
|
|
1,085,261
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
6,088,473
|
|
|
$
|
142,808
|
|
|
|
|
|
|
||||
|
Supplemental disclosure
|
|
|
|
||||
|
Cash paid during the year for:
|
|
|
|
||||
|
Interest
|
$
|
470,385
|
|
|
$
|
690,371
|
|
|
Income taxes
|
$
|
1,647,700
|
|
|
$
|
1,699,489
|
|
|
|
Jun 28, 2014
|
|
Dec 28, 2013
|
||||
|
Raw materials
|
$
|
21,322,927
|
|
|
$
|
16,557,350
|
|
|
Work-in-process
|
12,820,610
|
|
|
20,402,032
|
|
||
|
Finished goods
|
17,841,865
|
|
|
18,897,421
|
|
||
|
|
$
|
51,985,402
|
|
|
$
|
55,856,803
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
||||||||
|
Net sales
|
|
|
|
|
|
|
|
||||||||
|
Metals Segment
|
$
|
41,941,000
|
|
|
$
|
39,043,000
|
|
|
$
|
78,392,000
|
|
|
$
|
79,351,000
|
|
|
Specialty Chemicals Segment
|
16,856,000
|
|
|
14,404,000
|
|
|
33,291,000
|
|
|
27,580,000
|
|
||||
|
|
$
|
58,797,000
|
|
|
$
|
53,447,000
|
|
|
$
|
111,683,000
|
|
|
$
|
106,931,000
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
||||||
|
Metals Segment
|
$
|
4,041,000
|
|
|
$
|
1,882,000
|
|
|
$
|
7,027,000
|
|
|
$
|
3,478,000
|
|
|
Specialty Chemicals Segment
|
1,715,000
|
|
|
1,596,000
|
|
|
3,357,000
|
|
|
2,889,000
|
|
||||
|
|
5,756,000
|
|
|
3,478,000
|
|
|
10,384,000
|
|
|
6,367,000
|
|
||||
|
Unallocated expenses
|
|
|
|
|
|
|
|
||||||||
|
Corporate
|
1,057,000
|
|
|
833,000
|
|
|
1,956,000
|
|
|
1,639,000
|
|
||||
|
Acquisition related costs
|
—
|
|
|
13,000
|
|
|
(3,000
|
)
|
|
51,000
|
|
||||
|
Interest expense
|
262,000
|
|
|
372,000
|
|
|
528,000
|
|
|
714,000
|
|
||||
|
Change in fair value of interest rate swap
|
176,000
|
|
|
(495,000
|
)
|
|
294,000
|
|
|
(633,000
|
)
|
||||
|
Palmer earn-out adjustment
|
(3,476,000
|
)
|
|
—
|
|
|
(3,476,000
|
)
|
|
—
|
|
||||
|
Income from continuing operations
|
|
|
|
|
|
|
|
||||||||
|
before income taxes
|
$
|
7,737,000
|
|
|
$
|
2,755,000
|
|
|
$
|
11,085,000
|
|
|
$
|
4,596,000
|
|
|
|
|
Level 3 Inputs
|
||
|
Balance at December 28, 2013
|
|
$
|
5,862,031
|
|
|
Interest expense charged during 2014
|
|
60,000
|
|
|
|
Change in fair value of contingent consideration liability
|
|
(3,476,198
|
)
|
|
|
Balance at June 28, 2014
|
|
$
|
2,445,833
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
|
Jun 28, 2014
|
|
Jun 29, 2013
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net sales
|
$
|
4,557,000
|
|
|
$
|
2,827,000
|
|
|
$
|
9,512,000
|
|
|
$
|
7,178,000
|
|
|
(Loss) income before income taxes
|
(7,666,000
|
)
|
|
184,000
|
|
|
(8,303,000
|
)
|
|
557,000
|
|
||||
|
(Benefit from) provision for income taxes
|
(2,320,000
|
)
|
|
95,000
|
|
|
(2,521,000
|
)
|
|
240,000
|
|
||||
|
Net (loss) income from discontinued operations
|
(5,346,000
|
)
|
|
89,000
|
|
|
(5,782,000
|
)
|
|
317,000
|
|
||||
|
a)
|
The Company-wide cost cutting initiatives implemented in January 2014 had a favorable effect on profitability for the first six months of 2014. The Segment is meeting or exceeding all of the financial metric targets that were implemented.
|
|
b)
|
As mentioned above, BRISMET's product mix changed significantly in 2014. New sales pricing tools have allowed the sales department to focus on profitable sales quotes while backing away from low margin business.
|
|
c)
|
With the favorable trade case ruling against Vietnam, Malaysia and Thailand, BRISMET realized improved margins on all small diameter pipe.
|
|
d)
|
Sales and operating income for 2013 were significantly affected by the low margin Bechtel nuclear project. The facility successfully converted that effort to higher margin products in 2014.
|
|
e)
|
As a result of rising nickel prices during 2014, inventory losses decreased for the second quarter and first six months of 2014 compared to the prior year. Inventory losses were approximately $60,000 and $697,000 for the second quarter and first six months of 2014, respectively, compared to inventory losses of approximately $641,000 and $1,207,000, respectively, for the same periods of 2013. The Company experienced an inventory gain of $163,000 in June, 2014.
|
|
|
|
Original estimate
|
|
Current estimate
|
|
Difference
|
||||||
|
Year 2
|
|
$
|
2,500,000
|
|
|
$
|
—
|
|
|
$
|
2,500,000
|
|
|
Year 3
|
|
3,500,000
|
|
|
2,500,000
|
|
|
1,000,000
|
|
|||
|
Total
|
|
$
|
6,000,000
|
|
|
$
|
2,500,000
|
|
|
$
|
3,500,000
|
|
|
a)
|
Net accounts receivable increased $7,548,000 at June 28, 2014 when compared to the prior year end which resulted from consolidated sales for June 2014 increasing by 55 percent from December 2013;
|
|
b)
|
Net inventories decreased $3,871,000 as of June 28, 2014 compared to the end of 2013 due to the closure of Bristol Fab. This amount was partially offset by increased inventories at BRISMET as inventory lead times were lengthened by both steel suppliers during 2014 and additional inventory was required to support third quarter 2014 shipments;
|
|
c)
|
The Company generated cash during the second quarter of 2014 as accounts payable increased $6,536,000 as of June 28, 2014 from the prior year end due to the timing of raw material purchases late in the second quarter of 2014 combined with the Company experiencing an expansion in the number of accounts payable days outstanding; and
|
|
d)
|
Capital expenditures for the first six months of 2014 were $2,812,000, of which $1,714,000 was for the planned CRI Facility expansion.
|
|
Exhibit No.
|
|
Description
|
|
|
31.1
|
|
|
Rule 13a-14(a)/15d-14(a) Certifications of Chief Executive Officer
|
|
31.2
|
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer
|
|
32
|
|
|
Certifications Pursuant to 18 U.S.C. Section 1350
|
|
101.INS*
|
|
|
XBRL Instance Document
|
|
101.SCH*
|
|
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.LAB*
|
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*
|
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
101.DEF*
|
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
*
|
|
|
In accordance with Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall be deemed "furnished" and not "filed."
|
|
|
|
|
|
SYNALLOY CORPORATION
|
||
|
(Registrant)
|
||
|
|
|
|
|
|
|
|
|
Date: August 5, 2014
|
By:
|
/s/ Craig C. Bram
|
|
|
|
Craig C. Bram
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(principal executive officer)
|
|
|
|
|
|
Date: August 5, 2014
|
By:
|
/s/ Richard D. Sieradzki
|
|
|
|
Richard D. Sieradzki
|
|
|
|
Vice President, Finance and Chief Financial Officer
|
|
|
|
(principal accounting and financial officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|